TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000281043 MYCN NA NA malignant germ cell tumors up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA hepatic cancer up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA glioma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroendocrine prostate cancer up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroendocrine prostate cancer up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA glioblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN NA NA neuroblastoma up-regulated predicted more...
ENST00000281043 MYCN DB11672 Curcumin medulloblastoma down-regulated validated more...
ENST00000281043 MYCN DB05220 Alisertib (MLN8237) hepatocellular carcinoma down-regulated validated more...
ENST00000281043 MYCN NA JQ1 hepatocellular carcinoma down-regulated validated more...
ENST00000281043 MYCN DB00755 (NUTR00051, APRD00362) All-trans retinoic acid (ATRA) neuroblastoma down-regulated validated more...
ENST00000281043 MYCN NA Vasoactive intestinal peptide (VIP) neuroblastoma down-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3